N-[(2-Fluorophenyl)methyl]piperazine-1-carboxamide hydrochloride, 1g

Plan stress-free PLPOLi 100x/0.80 IOS objective for iScope incident polarization, no cover glass correction. Working distance 2 mm

(4S)-3-[(tert-butoxy)carbonyl]-1,3-thiazolidine-4-carboxylic acid, 99.0%, 25g

3-Bromo-5-fluorobenzaldehyde, 98.0%, 10g

5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dithione, 95%, 1g

TERT-BUTYL 7-METHYL-5-OXO-1,4-DIAZEPANE-1-CARBOXYLATE, 95.0%, 100mg

(R)-1-(3,3-Dimethyl-2-oxopentanoyl)piperidine-2-carboxylic acid, 97%, 100mg

1-((2-isopropyl-5-methylcyclohexyl)oxy)-3-(isopropylamino)propan-2-ol hydrochloride, 95.0%, 500mg

Ethyl 2-oxo-2-(pyridin-2-yl)acetate, 95.0%, 250mg

4-Methoxybutyl Acetate>98.0%(GC)1g

4-(2,3-Dichlorophenyl)-5-(methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylic acid, 95.0%, 5g

1-[(TERT-BUTYL)OXYCARBONYL]-3-[4-(TRIFLUOROMETHYL)BENZYL]PIPERIDINE-3-CARBOXYLIC ACID, 95.0%, 250mg

Thioanisole>99.0%(GC)100mL